Clinical Trial

Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture

Study acronym: DAICY
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Rational for conducting the study: Periprosthetic joint infection (PJI) is the most feared complication following prosthetic replacement of the hip joint and is associated with increased mortality, morbidity and economic burden. The aim of the trial is to investigate whether the risk of periprosthetic joint infection after treatment with hemiarthroplasty performed due to femoral neck fracture is reduced after the use of dual-impregnated antibiotic loaded cement. The primary outcome variable is the incidence of periprosthetic joint infection within one year after the index procedure. Secondary outcome variables include the occurrence of re-operations for any reason, bacteriology, antibiotic treatment, mortality and health care costs.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-12-17; most recent amendment 2026-03-09.
Status change: Recruiting → Active, Not Recruiting 2026-03-09
Status change: Not Yet Recruiting → Recruiting 2022-05-16
Trial Details
NCT Number NCT05164081
Lead Sponsor Umeå University
Collaborators: Region Västerbotten
Conditions Femoral Neck Fractures, Prosthetic Infection
Enrollment 7,000 participants
Start Date 2022-01-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-10